We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 4,207 results
  1. Myocardial Metabolic Reprogramming in HFpEF

    Abstract

    Heart failure (HF) caused by structural or functional cardiac abnormalities is a significant cause of morbidity and mortality worldwide....

    Zihui Zhang, Mingchu Sun, ... Heng Ma in Journal of Cardiovascular Translational Research
    Article 31 August 2023
  2. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics

    Lipid metabolic reprogramming is an emerging hallmark of cancer. In order to sustain uncontrolled proliferation and survive in unfavorable...

    Hao-Ran **, ** Wang, ... **-Lin Yang in Journal of Hematology & Oncology
    Article Open access 12 September 2023
  3. Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression

    TNF receptor associated factor 6 (TRAF6) is an E3 ubiquitin ligase that has been implicated in myeloid malignancies. Although altered TRAF6...

    Shinichiro Matsui, Chihiro Ri, ... Tomoya Muto in Leukemia
    Article Open access 12 April 2024
  4. Metabolic reprogramming in the tumor microenvironment of liver cancer

    The liver is essential for metabolic homeostasis. The onset of liver cancer is often accompanied by dysregulated liver function, leading to metabolic...

    Jian Lin, Dongning Rao, ... Qiang Gao in Journal of Hematology & Oncology
    Article Open access 31 January 2024
  5. Feedback loop between hypoxia and energy metabolic reprogramming aggravates the radioresistance of cancer cells

    Radiotherapy is one of the mainstream approaches for cancer treatment, although the clinical outcomes are limited due to the radioresistance of tumor...

    Zheng Shi, Cuilan Hu, ... Qiang Li in Experimental Hematology & Oncology
    Article Open access 22 May 2024
  6. Canagliflozin regulates metabolic reprogramming in diabetic kidney disease by inducing fasting-like and aestivation-like metabolic patterns

    Aims/hypothesis

    Sodium–glucose co-transporter 2 (SGLT2) inhibitors (SGLT2i) are antihyperglycaemic drugs that protect the kidneys of individuals with...

    Mingwei Shao, Duo Chen, ... Guijun Qin in Diabetologia
    Article 18 January 2024
  7. Hypoxia-induced PPFIA4 accelerates the progression of ovarian cancer through glucose metabolic reprogramming

    Dysregulated glycolysis promotes growth and metastasis, which is one of the metabolic characteristics of ovarian cancer. Based on bioinformatics...

    Shu Tan, Hao Yu, ... Ge Lou in Medical Oncology
    Article 18 August 2023
  8. Lipid metabolic reprogramming mediated by circulating Nrg4 alleviates metabolic dysfunction-associated steatotic liver disease during the early recovery phase after sleeve gastrectomy

    Background

    The metabolic benefits of bariatric surgery that contribute to the alleviation of metabolic dysfunction-associated steatotic liver disease...

    Chengcan Yang, Dongzi Zhu, ... Meiyi Li in BMC Medicine
    Article Open access 17 April 2024
  9. Oncogenic metabolic reprogramming in breast cancer: focus on signaling pathways and mitochondrial genes

    Oncogenic metabolic reprogramming impacts the abundance of key metabolites that regulate signaling and epigenetics. Metabolic vulnerability in the...

    Rhuthuparna Malayil, Yogita Chhichholiya, ... Anjana Munshi in Medical Oncology
    Article 11 May 2023
  10. Targeting metabolic reprogramming in chronic lymphocytic leukemia

    Metabolic reprogramming, fundamentally pivotal in carcinogenesis and progression of cancer, is considered as a promising therapeutic target against...

    Yu Nie, **aoya Yun, ... **n Wang in Experimental Hematology & Oncology
    Article Open access 27 June 2022
  11. RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer

    Background

    Triple negative breast cancer (TNBC), the most aggressive subtype of breast cancer, is characterized by a high incidence of brain...

    Yi-Qun Li, Fang-Zhou Sun, ... Fei Ma in Military Medical Research
    Article Open access 25 July 2023
  12. Thiamine-modified metabolic reprogramming of human pluripotent stem cell-derived cardiomyocyte under space microgravity

    During spaceflight, the cardiovascular system undergoes remarkable adaptation to microgravity and faces the risk of cardiac remodeling. Therefore,...

    **nglong Han, Lina Qu, ... Shijun Hu in Signal Transduction and Targeted Therapy
    Article Open access 08 April 2024
  13. ACOX1-mediated peroxisomal fatty acid oxidation contributes to metabolic reprogramming and survival in chronic lymphocytic leukemia

    Chronic lymphocytic leukemia (CLL) is still an incurable disease, with many patients develo** resistance to conventional and targeted therapies. To...

    Mariana Tannoury, Marianne Ayoub, ... Santos A. Susin in Leukemia
    Article 06 December 2023
  14. Fusobacterium nucleatum-triggered purine metabolic reprogramming drives tumorigenesis in head and neck carcinoma

    Background

    Fusobacterium nucleatum ( F. nucleatum ) is a vital pro-oncogenic bacterium. Our previous study revealed that a high abundance of F. nucleatum ...

    Feiran Li, Huiying Huang, ... Ming Zhang in Discover Oncology
    Article Open access 02 July 2023
  15. UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination

    Cancer cells rely on heightened protein quality control mechanisms, including the ubiquitin-proteosome system that is predominantly driven by...

    Meilin Ma, Changhui Zhang, ... **anghui Fu in Oncogene
    Article 22 October 2022
  16. Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy

    N 6 -methyladenosine (m 6 A) RNA methylation and its associated methyltransferase like 3 (METTL3) are involved in the development and maintenance of...

    Jun Gao, Yuan Fang, ... Yinghong Shi in Oncogene
    Article 07 July 2023
  17. Metabolic reprogramming of proinflammatory macrophages by target delivered roburic acid effectively ameliorates rheumatoid arthritis symptoms

    Rheumatoid arthritis (RA) is a common chronic inflammatory disorder that usually affects joints. It was found that roburic acid (RBA), an ingredient...

    Na Jia, Yunzhen Gao, ... Ling Zhang in Signal Transduction and Targeted Therapy
    Article Open access 28 July 2023
  18. The significance of lipid metabolism reprogramming of tumor-associated macrophages in hepatocellular carcinoma

    In the intricate landscape of the tumor microenvironment, tumor-associated macrophages (TAMs) emerge as a ubiquitous cellular component that...

    Qingjian **e, Yuan Zeng, ... Fujun Yu in Cancer Immunology, Immunotherapy
    Article Open access 02 July 2024
  19. NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity

    Neurofibromatosis type 2 ( NF2 ) is a tumor suppressor gene implicated in various tumors, including mesothelioma, schwannomas, and meningioma. As a...

    Duo Xu, Shiyuan Yin, Yongqian Shu in npj Precision Oncology
    Article Open access 15 June 2024
Did you find what you were looking for? Share feedback.